Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$99,333,716
+$1,312,298 QoQ
Shares Held
222,452
+2.9% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AVIVA PLC holds $267,602,543 across 25 Biotechnology names. VRTX ranks #1 (37.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
222,452 | $99,333,716 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
91,176 | $70,446,224 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
114,003 | $37,720,172 | |
| 4 | INSM |
INSMED Inc
|
122,074 | $19,961,540 | |
| 5 | RPRX |
Royalty Pharma plc
|
323,823 | $15,533,789 | |
| 6 | INCY |
Incyte Corp
|
148,088 | $13,938,042 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
21,460 | $2,086,985 | |
| 8 | EXEL |
Exelixis, Inc.
|
25,153 | $1,078,812 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,333,716 | 222,452 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $98,021,418 | 216,211 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $80,242,727 | 204,889 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $85,772,232 | 192,660 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $87,602,125 | 180,690 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $62,615,823 | 155,490 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $58,060,587 | 124,840 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $57,144,936 | 121,917 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $40,965,398 | 98,001 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $51,668,112 | 126,983 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $38,121,345 | 109,626 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,476,047 | 100,810 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $49,271,276 | 156,382 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $43,969,931 | 152,261 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $49,512,787 | 171,005 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $54,898,609 | 194,821 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $38,557,795 | 147,748 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $20,537,870 | 93,524 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $18,527,355 | 102,141 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $19,379,869 | 96,116 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $18,686,834 | 86,960 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $20,650,443 | 87,376 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $22,814,812 | 83,841 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $25,127,201 | 86,553 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $21,670,820 | 91,073 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||